Rapid progression in Drug Delivery techniques will bolster the Oral Controlled Release Drug Delivery Technology Market to reach US$ 68.4 Bn by 2032 end. Data by Future Market Insights, Inc.
globenewswire.com
science
2022-10-17 10:30:00

NEWARK, Del, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The global oral controlled release drug delivery technology market is expected to reach a value of US$ 68.4 Bn in 2032, with sales growing at a healthy CAGR of 7.2% from 2022 to 2032. Valued at US$ 31.8 Bn in 2021, the target market is expected to reach an estimated US$ 34.1 Bn in 2022. The surge in chronic illnesses coupled with high preference for oral drug delivery owing to various advantages will fuel the growth of the oral controlled release drug delivery technology market over the forecast period.
